Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 17 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Roche Holding AG, Organon & Co, Sanofi, Bristol-Myers Squibb Co, Johnson & Johnson, Merck & Co Inc, Eli Lilly and Co, Glaxosmithkline PLC, Perrigo Co Plc, Viatris Inc., Novo Nordisk A/S, Novartis AG, Pfizer Inc, Catalent Inc, Roche Holding AG, Astrazeneca PLC and Zoetis Inc.
9/17/2021 Health Care Sector Pharmaceuticals Industry
$15,493
Change: -0.61%
Open: $15,514
High: $15,589
Low: $15,357
| Roche Holding AG (RHHBF) |
+1.21%
|
| Organon & Co (OGN) |
+0.80%
|
| Sanofi (SNY) |
+0.39%
|
| Bristol-Myers Squibb Co (BMY) |
+0.13%
|
| Johnson & Johnson (JNJ) |
-0.28%
|
| Merck & Co Inc (MRK) |
-0.40%
|
| Eli Lilly and Co (LLY) |
-0.41%
|
| Glaxosmithkline PLC (GSK) |
-0.46%
|
| Pharmaceuticals Industry |
-0.61%
|
| Perrigo Co Plc (PRGO) |
-0.77%
|
| Viatris Inc. (VTRS) |
-0.88%
|
| Novo Nordisk A/S (NVO) |
-0.95%
|
| Novartis AG (NVS) |
-1.07%
|
| Pfizer Inc (PFE) |
-1.30%
|
| Catalent Inc (CTLT) |
-1.46%
|
| Roche Holding AG (RHHBY) |
-1.60%
|
| Astrazeneca PLC (AZN) |
-1.84%
|
| Zoetis Inc (ZTS) |
-2.11%
|
Index Value: $15,493 -0.61%
Volume: 3.06B Average Volume (3 month): 1.70B
Market Capitalization: $45.06T
EBITDA: $4.05T
EPS Basic: $170.67 Diluted: $91.28 Actual: $218.00
EPS Estimation: High $214.95 Medium: $202.46 Low: $190.03
EPS TTM: $372.62
P/E: 45.75
PEG Ratio (5 year Expected): 13.35
Dividend Yield: 5.36%
Dividend Rate: $837.68
Dividend Yield (Forward): 2.69%
Dividend Rate (Forward): $422.37
Shares Outstanding: 731.29B
Book Value: $2,965
Short Ratio: 1.83
Price Target (1 year): $16,131
Volume: 3.06B Average Volume (3 month): 1.70B
Market Capitalization: $45.06T
EBITDA: $4.05T
EPS Basic: $170.67 Diluted: $91.28 Actual: $218.00
EPS Estimation: High $214.95 Medium: $202.46 Low: $190.03
EPS TTM: $372.62
P/E: 45.75
PEG Ratio (5 year Expected): 13.35
Dividend Yield: 5.36%
Dividend Rate: $837.68
Dividend Yield (Forward): 2.69%
Dividend Rate (Forward): $422.37
Shares Outstanding: 731.29B
Book Value: $2,965
Short Ratio: 1.83
Price Target (1 year): $16,131
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| RHHBF | Roche Holding AG | 417.00 | +1.21% | 26 | 0.17 | 11.74% |
| OGN | Organon & Co | 34.03 | +0.80% | 3.72M | 1.40 | 0.30% |
| SNY | Sanofi | 48.38 | +0.39% | 7.59M | 3.91 | 4.28% |
| BMY | Bristol-Myers Squibb Co | 61.31 | +0.13% | 17.38M | 2.04 | 4.80% |
| JNJ | Johnson & Johnson | 164.75 | -0.28% | 7.48M | 1.26 | 15.29% |
| MRK | Merck & Co Inc | 71.68 | -0.40% | 40.52M | 4.06 | 6.47% |
| LLY | Eli Lilly and Co | 230.10 | -0.41% | 4.19M | 1.53 | 7.76% |
| GSK | Glaxosmithkline PLC | 38.93 | -0.46% | 3.32M | 0.84 | 3.45% |
| Pharmaceuticals Industry | 15,493.18 | -0.61% | 3.06B | 1.80 | 41.97% | |
| PRGO | Perrigo Co Plc | 43.94 | -0.77% | 16.18M | 11.10 | 0.21% |
| VTRS | Viatris Inc. | 13.57 | -0.88% | 22.84M | 3.27 | 0.58% |
| NVO | Novo Nordisk A/S | 101.41 | -0.95% | 1.49M | 1.50 | 8.21% |
| NVS | Novartis AG | 83.48 | -1.07% | 2.00M | 1.15 | 6.61% |
| PFE | Pfizer Inc | 43.89 | -1.30% | 51.51M | 1.64 | 8.68% |
| CTLT | Catalent Inc | 136.15 | -1.46% | 2.76M | 3.43 | 0.82% |
| RHHBY | Roche Holding AG | 46.07 | -1.60% | 1.82M | 1.71 | 11.41% |
| AZN | Astrazeneca PLC | 55.56 | -1.84% | 6.88M | 0.69 | 6.07% |
| ZTS | Zoetis Inc | 198.49 | -2.11% | 3.87M | 2.57 | 3.33% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| RHHBF | Roche Holding AG | 312.034B | N/A | N/A | 2.10% | |
| OGN | Organon & Co | 8.562B | N/A | N/A | -5.68 | |
| SNY | Sanofi | 121.064B | $5.26 | 9.99 | 6.67% | 1.86 |
| BMY | Bristol-Myers Squibb Co | 135.993B | -$2.27 | N/A | 3.10% | 1.20 |
| JNJ | Johnson & Johnson | 434.622B | $5.66 | 31.71 | 2.47% | 2.04 |
| MRK | Merck & Co Inc | 182.005B | $2.06 | 38.27 | 3.46% | 1.09 |
| LLY | Eli Lilly and Co | 220.98B | $6.67 | 40.89 | 1.36% | 2.23 |
| GSK | Glaxosmithkline PLC | 98.396B | $2.87 | 14.75 | 2.04% | 3.29 |
| Pharmaceuticals Industry | $45.06T | $372.62 | 45.75 | 5.36% | 13.35 | |
| PRGO | Perrigo Co Plc | 5.93B | -$3.24 | N/A | 2.04% | 1.67 |
| VTRS | Viatris Inc. | 16.555B | -$1.80 | N/A | 1.60% | 10.40 |
| NVO | Novo Nordisk A/S | 234.908B | $3.02 | 34.75 | 9.23% | 145.99 |
| NVS | Novartis AG | 189.173B | $3.48 | 27.34 | 4.00% | 1.87 |
| PFE | Pfizer Inc | 249.161B | $1.50 | 33.61 | 3.44% | 0.92 |
| CTLT | Catalent Inc | 23.57B | $2.97 | 40.63 | 2.41 | |
| RHHBY | Roche Holding AG | 329.44B | N/A | N/A | 19.42% | |
| AZN | Astrazeneca PLC | 175.362B | $0.96 | 61.82 | 4.96% | 0.84 |
| ZTS | Zoetis Inc | 96.343B | $3.99 | 51.78 | 0.44% | 3.41 |
Back to Market Summary